Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II
- 20 February 1992
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 223 (4), 837-843
- https://doi.org/10.1016/0022-2836(92)90245-f
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugsBiochemical and Biophysical Research Communications, 1987
- DNA sequence of theE. coli gyrB gene: application of a new sequencing strategyNucleic Acids Research, 1987
- The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)Biochemical and Biophysical Research Communications, 1986
- Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39Nucleic Acids Research, 1986
- Mechanistic Aspects of DNA TopoisomerasesAdvances in protein chemistry, 1986
- DNA topoisomerases as targets for cancer therapyBiochemical Pharmacology, 1985
- Structure and function of the region of the replication origin of theBacillus subtilischromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin regionNucleic Acids Research, 1985